Tory leader calls for resignations at NHS Fife over Sandie Peggie tribunal
Ms Peggie was suspended from her job as an A&E nurse at the Victoria Hospital in Kirkcaldy in 2024 after complaining about having to share a changing room with trans medic Dr Beth Upton.
Ms Peggie took the board to an employment tribunal which began earlier this year.
But this week, Ms Peggie was cleared of a bullying and harassment complaint from Dr Upton, as the tribunal reconvened.
Mr Findlay has called for NHS Fife chief executive Carol Potter to resign, along with the authority's board, and if they refuse, the Scottish Government should step in and sack them, he said.
'This ongoing slow-motion car crash from NHS Fife confirms that Carol Potter and her entire board can no longer remain in post,' the Scottish Tory leader said.
'In their zeal to embrace the SNP's bonkers belief in gender ideology, they were willing to destroy the career of a nurse and waste huge sums of taxpayers' money.'
Mr Findlay claimed the board was 'smearing Sandie Peggie and the campaigners who have stood with her'.
On Friday, the board released a lengthy statement claiming there had been a threat of 'physical harm and sexual violence' in relation to the tribunal, but clarified this is not believed to be related to any of Ms Peggie's supporters.
An earlier version of the statement had referenced the involvement of the campaign group Sex Matters.
'The claimant's case is being supported by Sex Matters, whose chief executive officer and co-founder was called as a witness by the claimant in the earlier hearing.
'The claimant's barrister is also chair of Sex Matters.
'Other members of the organisation's 'advisory group' have provided commentary to the media on a number of occasions where no reference is made to their direct involvement.'
The updated version of the statement removed reference to the group's involvement in the tribunal and inserted two notes saying the board 'is not seeking to suggest that Sex Matters have contributed to the behaviour or issues mentioned'.
Mr Findlay added: ' John Swinney, Neil Gray and their SNP colleagues appear to be the only people left in Scotland who think this is OK.
'If the NHS Fife board won't do the right thing and quit, then they should be sacked.'
A spokesperson for NHS Fife said: 'As this is an active legal case, it would be inappropriate to respond to these comments.'
A Scottish Government spokesperson said: 'It would be inappropriate to comment further while judicial proceedings in an employment tribunal are ongoing.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
43 minutes ago
- Daily Mail
Mysterious condition reappears as Trump visits Scotland amid concerns over his chronic diagnosis
Donald Trump appeared with makeup on his hands again during his trip to Scotland just weeks after the White House explained the president's mysterious bruises. The Daily Mail first reported on Trump's mysterious hand bruising back in February, revealing that Trump's glad-handing had brought on the result. Earlier this month, Trump, 79, appeared at a White House press gaggle with what looked like makeup covering a patch on the back of his hand, sparking concerns. 'This is consistent with minor soft-tissue irritation from frequent handshaking and use of aspirin, which is taken as part of a standard cardiovascular prevention regimen. This is a well-known and benign side effect of aspirin therapy,' White House Press Secretary Karoline Leavitt recently divulged. The president has spent the past few days in Scotland meeting with everyone from UK Prime Minister Keir Starmer to European Commission President Ursula von der Leyen. The makeup covering those bruises has been visible in multiple press photos throughout Trump's trip. Once again, the president appears to be using a lot of concealer to keep the bruise from showing up when he announced a new trade deal with the EU. The makeup appeared to be concealing a raised circular area of skin that Trump's team may have been eager to hide. Earlier this month, in a surprise statement from the podium during a press briefing, White House Press Secretary Karoline Leavitt told reporters the president was checked out by his doctor after noticeable 'swelling' and revealed that Trump has been diagnosed with 'chronic venous insufficiency.' The splotch has been visible on other occasions throughout the past month, sparking a new round of questions about the cause. The makeup appeared to be concealing a raised circular area of skin. Leavitt said during her rare medical update that the president recently ' noticed mild swelling in the lower legs' and 'in keeping with routine medical care and out of the abundance of caution,' he was evaluated by the White House medical unit. He underwent a 'comprehensive examination' which included 'diagnostic vascular studies.' 'Bilateral, lower extremity ultrasounds were performed and revealed chronic venous insufficiency,' Leavitt stated. She said it's a 'common condition' in individuals over the age of 70 and there was 'no evidence' of deep vein thrombosis or arterial disease. 'The president remains in excellent health,' Leavitt said overall. 'Importantly, there was no evidence of deep vein thrombosis or arterial disease,' she added. Leavitt said in response to a question that there was 'no discomfort from the president at all.' She then pointed to his daily activities. 'And you probably all see that on a day-to-day basis, he's working around the clock. As for the treatment, I can defer to the president's physician,' she said. The letter released by White House Physician Sean Barbarella, DO, references 'mild swelling' in Trump's lower legs, and states the diagnosis emerged after a series of vascular studies. Neither Leavitt nor the letter addressed whether Trump would have to modify any of his routines, which include frequent golfing at his private courses on weekends, and his trademark dance moves to 'Y.M.C.A.' when he addresses rally crowds. Leavitt said there was 'no discomfort' for the president at all. Officials have previously mentioned Trump's frequent handshaking – Trump regularly interacts with a large number of people at White House events and when he travels – as the cause of the bruising, but have not previously identified the aspirin issue. The bruising had stayed with Trump from the presidential campaign through his return to the White House. It had even been spotted during Trump's Manhattan court fight in the Stormy Daniels case. According to the Cleveland Clinic, chronic venous insufficiency occurs when leg veins are damaged, making it more difficult for blood to return to the heart. It 'causes blood to pool in your leg veins, leading to high pressure in those veins.' The condition is fairly common, affecting one in 20 adults, and the risk increases with age. It can lead to achy legs, a feeling of 'pins and needles,' cramping, swelling and itching, as well as 'Leathery-looking skin on your legs.' Up to half the people who have had deep vein thrombosis later develop post-thrombotic syndrome within a year or two. That relates to scar tissue that can develop after a blood clot. Trump was the oldest person to take the Oath of Office when he was sworn in in January at age 78. He has said repeatedly that his predecessor Joe Biden, 82, had no idea what he was doing and this week opened a probe into an alleged 'cover-up' through his use of an autopen for a series of commutations. Trump reposted an item in May calling Biden a 'decrepit corpse,' days after Biden got a prostate cancer diagnosis. Trump has made a point of demonstrating his own physical and mental vigor – taking question after question from reporters inside the Oval Office, sometimes speaking for up to an hour.
The Guardian
an hour ago
- The Guardian
Edinburgh University's ‘skull room' highlights its complicated history with racist science
Hundreds of skulls are neatly and closely placed, cheekbone to cheekbone, in tall, mahogany-framed glass cabinets. Most carry faded, peeling labels, some bear painted catalogue numbers; one has gold teeth; and the occasional one still carries its skin tissue. This is the University of Edinburgh's 'skull room'. Many were voluntarily donated to the university; others came from executed Scottish murderers; some Indigenous people's skulls were brought to Scotland by military officers on expeditions or conquest missions. Several hundred were collected by supporters of the racist science of phrenology – the discredited belief that skull shape denoted intelligence and character. Among them are the skulls of two brothers who died while studying at Edinburgh. Their names are not recorded in the skull room catalogue, but cross-referencing of matriculation and death records suggests they were George Richards, a 21-year-old medic who died of smallpox in 1832, and his younger brother, Robert Bruce, 18, a divinity scholar who died of typhoid fever in 1833. Exactly how the Richards brothers' skulls came to be separated from their bodies, recorded as interned in the South Leith parish church cemetery, is unknown. But they were almost certainly acquired by the Edinburgh Phrenological Society to study supposed racial difference. Researchers believe their case exemplifies the challenging questions facing the university, which, it has now emerged, played a pivotal role in the creation and perpetuation of racist ideas about white superiority and racial difference from the late 1700s onwards – ideas taught to thousands of Edinburgh students who dispersed across the British empire. University records studied by Dr Simon Buck suggest the brothers were of mixed African and European descent, born in Barbados to George Richards, an Edinburgh-educated doctor who practised medicine on sugar plantations and who owned enslaved people – possibly including George and Robert Bruce's mother. Edinburgh Phrenological Society's 1858 catalogue records the skulls (listed as No 1 and No 2) as having belonged to 'mulatto' students of divinity and medicine. 'It can be assumed that the racialisation of these two individuals as 'mulatto' – a hybrid racial category that both fascinated and bewildered phrenologists – is what aroused interest among members of the society in the skulls of these two students,' Edinburgh's decolonisation report concludes. The brothers' skulls are among the roughly 400 amassed by the society and later absorbed into the anatomical museum's collection, which now contains about 1,500 skulls. These are held in the Skull Room, to which The Guardian was granted rare access. Many of these ancestral remains, the report states, 'were taken, without consent, from prisons, asylums, hospitals, archaeological sites and battlefields', with others 'having been stolen and exported from the British empire's colonies', often gifted by a global network of Edinburgh alumni. 'We can't escape the fact that some of [the skulls] will have been collected with the absolute express purpose of saying, 'This is a person from a specific race, and aren't they inferior to the white man',' said Prof Tom Gillingwater, the chair of anatomy at the University of Edinburgh, who now oversees the anatomical collection. 'We can't get away from that.' The Edinburgh Phrenological Society was founded by George Combe, a lawyer, and his younger brother, Andrew, a doctor, with roughly a third of its early members being physicians. Both were students at the university, and some Edinburgh professors were active members. Through its acquisition of skulls from across the globe, the society played a central role in turning the 'science' of phrenology, which claimed to decode an individual's intellect and moral character from bumps and grooves on the skull, into a tool of racial categorisation that placed the white European man at the top of a supposed hierarchy. George Combe's book, The Constitution of Man, was a 19th-century international bestseller and the Combe Trust (founded with money made from books and lecture tours promoting phrenology) endowed Edinburgh's first professorship in psychology in 1906 and continues to fund annual Combe Trust fellowships in the Institute for Advanced Studies in the Humanities. Phrenology was criticised by some of Edinburgh's medical elite for its unscientific approach. But some of its most vocal critics were nonetheless persuaded that immutable biological differences in intelligence and temperament existed between populations, a study by Dr Ian Stewart for the university's decolonisation report reveals. These included Alexander Monro III, an anatomy professor at the University of Edinburgh medical school, who lectured 'that the Negro skull, and consequently the brain, is smaller than that of the European', and Robert Jameson, a regius professor of natural history, whose lectures at the university in the 1810s included a hierarchical racial diagram of brain size and intelligence. Despite the fact that phrenology was never formally taught at Edinburgh, and its accuracy was heavily contested by Edinburgh academics, the skull room, which is closed to the public, was built partly to house its collection by the then professor of anatomy Sir William Turner, when he helped oversee the construction of its new medical school in the 1880s. Among its reparatory justice recommendations of Edinburgh's investigation is that the university provide more support for the repatriation of ancestral remains to their original communities. This, Gillingwater suggested, possibly underplays the complexities involved – even for cases such as the Richards brothers. He regards the circumstantial evidence in their case as 'strong' but says it does not meet the forensic threshold required for conclusive identification. 'From a legal perspective, it wouldn't be watertight,' said Gillingwater. 'I would never dream of returning remains to a family when I didn't know who they definitely were.' Active engagement surrounding repatriation is taking place in relation to several of the skulls from the phrenology collection; more than 100 have already been repatriated to their places of origin. But each case takes time building trust with communities and in some cases navigating geopolitical tensions over which descendent community has the strongest claim to the remains. 'To look at perhaps repatriation, burials, or whatever, it's literally years of work almost for each individual case,' said Gillingwater. 'And what I found is that every individual culture you deal with wants things done completely differently.' Many of the skulls will never be identified and their provenance is likely to remain unknown. 'That is something that keeps me awake at night,' said Gillingwater. 'For some of our skulls, I know that whatever we do, we're never going to end up with an answer.' 'All I can offer at the minute is that we just continue to care for them,' he added. 'They've been with us, many of them, for a couple of hundred years. So we can look after them. We can care for them. We can treat them with that dignity and respect they all deserve individually.'
Times
7 hours ago
- Times
Scientists' discovery could stop breast cancer spreading
Scottish scientists have made a discovery that could help stop breast cancer spreading to other parts of the body. Experts at Cancer Research UK Scotland Institute and the University of Glasgow have found there are key metabolic changes that take place before tumours grow elsewhere. Their work is being hailed as a significant breakthrough because it is often cancer moving from the breast that kills patients. • How I told my sons that I had a rare form of breast cancer Researchers writing in the journal EMBO Reports said identifying the metabolic changes offered a vital window to intervene. Detecting these changes early could allow therapies to stop cancer cells moving around the body and forming tumours elsewhere. Dr Cassie Clarke, lead researcher, said: 'This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' About 56,800 people are diagnosed with breast cancer in the United Kingdom each year and 11,300 people lose their lives to the disease. Dr Catherine Elliott, Cancer Research UK's director of research, said: 'Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. • Why the way we diagnose, label and treat cancer is changing 'However, metastasis — when cancer spreads — is a major factor in breast cancer becoming harder to treat, especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' The study focused on how breast cancer changes the immune system so it cannot tackle cancer cells as they begin their spread. The researchers found that cancer changes the metabolism — the way cells make and use energy — of specific immune cells, resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. This opens the door to potentially powerful new tools to tackle cancer. Detecting uracil in the blood could help spot early signs of cancer spread, while blocking UPP1 with drugs could stop the spread before it starts. • The Times View: It is time to be optimistic about cancer The research was funded by Cancer Research UK, the Wellcome Trust, the Medical Research Council, Breast Cancer Now and Pancreatic Cancer UK. Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital.' The team are further investigating exactly how UPP1 changes the behaviour of immune cells, exploring the role of immune cell metabolism in early breast cancer initiation, and testing the ability of drugs that block immune cell metabolism to prevent cancer occurring.
